ClinicalTrialsFinder

EGFR P-Loop and Alpha C-Helix Compressing Clinical Trials in Akashi-shi, Hyōgo

1 recruitingAkashi-shi, Hyōgo, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 3

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Non-small Cell Lung CancerAdvanced Non-Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer+3 more
ArriVent BioPharma, Inc.480 enrolled74 locationsNCT07185997